Losartan alters osteoblast differentiation and increases bone mass through inhibition of TGFB signalling in vitro and in an OIM mouse model (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bonr.2024.101795
Publication URI: http://dx.doi.org/10.1016/j.bonr.2024.101795
Type: Journal Article/Review
Parent Publication: Bone Reports